BIO-key International Q4 2025 Earnings Call: Revenue Decline, EMEA Transition, and 2026 Outlook

BIO-key International reported a 12% decline in 2025 revenue, primarily due to a $1.5 million license renewal in 2024 and a strategic transition in the EMEA region. However, the company completed its shift to selling only BIO-key-branded solutions in EMEA, which is expected to drive higher net margins and pipeline quality. Performance was bolstered by a 100% increase in hardware revenue, reflecting growing demand for biometric readers in zero-trust environments. Management expects Q1 2026 revenue to be approximately $2.2 million, representing a 37% year-over-year increase. The company is targeting breakeven and positive cash flow in early 2026, supported by a shift toward a predominantly subscription-based model.